Aires Blood and Biological Research: Animal and Laboratory Evidence

Aires-related biological research includes blood measurements in rats, chromosome studies, honeybee gene-expression work and tests on isolated human blood samples. These cannot be pooled as if they were human clinical trials. This guide identifies the organism and endpoint behind each claim.

Behavior and blood parameters in rats, 2025

The Pavlov Institute/SFERA report examines rats from two nervous-system excitability lines with router exposure and Lifetune Zone Max. Selected behavioral and blood differences favored the combined condition. Other outcomes were nonsignificant or did not show uniform protection. Sample-size reporting, RF settings and cage controls require clarification. This is not a 30-person human trial.

Read the study summary · Original English report (PDF).

Chromosome aberrations in rats, 2018–2019

Published work reports lower chromosome-aberration frequencies in selected router-plus-resonator conditions than router-only conditions. The 2019 paper reports different responses across rat lines; in the high-excitability line, the reported values were 9.8% and 2.7%. These are animal observations under the experimental protocol, not a quantified reduction in human disease risk. Related staged reports and journal versions overlap and must not be counted as independent replications.

2018 paper (PDF) · 2019 paper (PDF) · 2019 publisher DOI.

hsp70 gene expression in honeybees, 2019

The identifiable Stage V report concerns hsp70 gene expression in honeybee brains. Router exposure reduced the measured transcript signal, and the router-plus-device condition moved it toward control levels. Devices alone showed no significant change. The endpoint was RNA assessed with PCR and gel densitometry—not a direct assay of HSP70 protein, neuron death or clinical recovery.

Read the original Stage V report (PDF). The earlier references on this page to two 2024 Scientific Reports rat HSP70 papers were not supported by matching source records and have been removed.

Isolated human blood samples, 2005

Tarlykov investigated erythrocyte osmotic properties in ten samples from patients with multiple myeloma. Responses varied with sample and exposure duration. There was no randomized sham or time control, no RF challenge and no clinical outcome. A later archival presentation describes the same investigation; it is not a new 2019 experiment.

Read the original Tarlykov report (PDF).

Sources and disclosure

This is an Aires editorial summary. Aires sells the products discussed and has a commercial interest in the research. Institutional affiliation, an external author, or a third-party opinion alone does not establish financial independence. Where a linked report does not establish funding or the sponsor’s role, those details remain unconfirmed. Original researchers retain authorship of their work.

The original-source evidence library distinguishes journal articles, conference papers, research reports and expert opinions. Reports, translations and later manuscripts describing the same experiment should not be counted as independent replications.

Editorial update: October 25, 2026 · Josh, Aires. This page explains research and its limitations; it is not a diagnosis or a claim that an Aires product prevents or treats disease.